Antisense & RNAi Therapeutics Market Size, Share & Trends Report

Antisense & RNAi Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Pulmonary Delivery, Intravenous Injection), By Application (CVDs, Oncology), By Technology, And Segment Forecasts, 2019 - 2025

  • Published Date: Jun, 2019
  • Base Year for Estimate: 2018
  • Report ID: 978-1-68038-805-3
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 161

Market Segmentation

  • Antisense & RNAi Therapeutics Technology Outlook (Revenue, USD Million, 2014 - 2025)
    • RNA Interference
      • siRNA
      • miRNA
    • Antisense RNA
  • Antisense & RNAi Therapeutics Application Outlook (Revenue, USD Million, 2014 - 2025)
    • Oncology
    • Cardiovascular
    • Respiratory Disorders
    • Renal Diseases
    • Neurodegenerative Disorders
    • Genetic Disorders
    • Infectious Diseases
    • Other
  • Antisense & RNAi Therapeutics Route of Administration Outlook (Revenue, USD Million, 2014 - 2025)
    • Pulmonary Delivery
    • Intravenous Injections
    • Intradermal Injections
    • Intraperitoneal Injections
    • Topical Delivery
    • Other Delivery Methods
  • Antisense & RNAi Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • North America Antisense & RNAi Therapeutics Market, by Technology
        • RNA Interference
          • siRNA
          • miRNA
        • Antisense RNA
      • North America Antisense & RNAi Therapeutics Market, by Application
        • Oncology
        • Cardiovascular
        • Respiratory Disorders
        • Renal Diseases
        • Neurodegenerative Disorders
        • Genetic Disorders
        • Infectious Diseases
        • Other
      • North America Antisense & RNAi Therapeutics Market, by Route of Administration
        • Pulmonary Delivery
        • Intravenous Injections
        • Intradermal Injections
        • Intraperitoneal Injections
        • Topical Delivery
        • Other Delivery Methods
      • The U.S. 
        • U.S. Antisense & RNAi Therapeutics Market, by Technology
          • RNA Interference
            • siRNA
            • miRNA
          • Antisense RNA
        • U.S. Antisense & RNAi Therapeutics Market, by Application
          • Oncology
          • Cardiovascular
          • Respiratory Disorders
          • Renal Diseases
          • Neurodegenerative Disorders
          • Genetic Disorders
          • Infectious Diseases
          • Other
        • U.S. Antisense & RNAi Therapeutics Market, by Route of Administration
          • Pulmonary Delivery
          • Intravenous Injections
          • Intradermal Injections
          • Intraperitoneal Injections
          • Topical Delivery
          • Other Delivery Methods
      • Canada 
        • Canada Antisense & RNAi Therapeutics Market, by Technology
          • RNA Interference
            • siRNA
            • miRNA
          • Antisense RNA
        • Canada Antisense & RNAi Therapeutics Market, by Application
          • Oncology
          • Cardiovascular
          • Respiratory Disorders
          • Renal Diseases
          • Neurodegenerative Disorders
          • Genetic Disorders
          • Infectious Diseases
          • Other
        • Canada Antisense & RNAi Therapeutics Market, by Route of Administration
          • Pulmonary Delivery
          • Intravenous Injections
          • Intradermal Injections
          • Intraperitoneal Injections
          • Topical Delivery
          • Other Delivery Methods
    • Europe 
      • Europe Antisense & RNAi Therapeutics Market, by Technology
        • RNA Interference
          • siRNA
          • miRNA
        • Antisense RNA
      • Europe Antisense & RNAi Therapeutics Market, by Application
        • Oncology
        • Cardiovascular
        • Respiratory Disorders
        • Renal Diseases
        • Neurodegenerative Disorders
        • Genetic Disorders
        • Infectious Diseases
        • Other
      • Europe Antisense & RNAi Therapeutics Market, by Route of Administration
        • Pulmonary Delivery
        • Intravenous Injections
        • Intradermal Injections
        • Intraperitoneal Injections
        • Topical Delivery
        • Other Delivery Methods
      • Germany 
        • Germany Antisense & RNAi Therapeutics Market, by Technology
          • RNA Interference
            • siRNA
            • miRNA
          • Antisense RNA
        • Germany Antisense & RNAi Therapeutics Market, by Application
          • Oncology
          • Cardiovascular
          • Respiratory Disorders
          • Renal Diseases
          • Neurodegenerative Disorders
          • Genetic Disorders
          • Infectious Diseases
          • Other
        • Germany Antisense & RNAi Therapeutics Market, by Route of Administration
          • Pulmonary Delivery
          • Intravenous Injections
          • Intradermal Injections
          • Intraperitoneal Injections
          • Topical Delivery
          • Other Delivery Methods
      • U.K. 
        • U.K. Antisense & RNAi Therapeutics Market, by Technology
          • RNA Interference
            • siRNA
            • miRNA
          • Antisense RNA
        • U.K. Antisense & RNAi Therapeutics Market, by Application
          • Oncology
          • Cardiovascular
          • Respiratory Disorders
          • Renal Diseases
          • Neurodegenerative Disorders
          • Genetic Disorders
          • Infectious Diseases
          • Other
        • U.K. Antisense & RNAi Therapeutics Market, by Route of Administration
          • Pulmonary Delivery
          • Intravenous Injections
          • Intradermal Injections
          • Intraperitoneal Injections
          • Topical Delivery
          • Other Delivery Methods
    • Asia Pacific 
      • Asia Pacific Antisense & RNAi Therapeutics Market, by Technology
        • RNA Interference
          • siRNA
          • miRNA
        • Antisense RNA
      • Asia Pacific Antisense & RNAi Therapeutics Market, by Application
        • Oncology
        • Cardiovascular
        • Respiratory Disorders
        • Renal Diseases
        • Neurodegenerative Disorders
        • Genetic Disorders
        • Infectious Diseases
        • Other
      • Asia Pacific Antisense & RNAi Therapeutics Market, by Route of Administration
        • Pulmonary Delivery
        • Intravenous Injections
        • Intradermal Injections
        • Intraperitoneal Injections
        • Topical Delivery
        • Other Delivery Methods
      • China 
        • China Antisense & RNAi Therapeutics Market, by Technology
          • RNA Interference
            • siRNA
            • miRNA
          • Antisense RNA
        • China Antisense & RNAi Therapeutics Market, by Application
          • Oncology
          • Cardiovascular
          • Respiratory Disorders
          • Renal Diseases
          • Neurodegenerative Disorders
          • Genetic Disorders
          • Infectious Diseases
          • Other
        • China Antisense & RNAi Therapeutics Market, by Route of Administration
          • Pulmonary Delivery
          • Intravenous Injections
          • Intradermal Injections
          • Intraperitoneal Injections
          • Topical Delivery
          • Other Delivery Methods
      • Japan 
        • Japan Antisense & RNAi Therapeutics Market, by Technology
          • RNA Interference
            • siRNA
            • miRNA
          • Antisense RNA
        • Japan Antisense & RNAi Therapeutics Market, by Application
          • Oncology
          • Cardiovascular
          • Respiratory Disorders
          • Renal Diseases
          • Neurodegenerative Disorders
          • Genetic Disorders
          • Infectious Diseases
          • Other
        • Japan Antisense & RNAi Therapeutics Market, by Route of Administration
          • Pulmonary Delivery
          • Intravenous Injections
          • Intradermal Injections
          • Intraperitoneal Injections
          • Topical Delivery
          • Other Delivery Methods
    • Latin America 
      • Latin America Antisense & RNAi Therapeutics Market, by Technology
        • RNA Interference
          • siRNA
          • miRNA
        • Antisense RNA
      • Latin America Antisense & RNAi Therapeutics Market, by Application
        • Oncology
        • Cardiovascular
        • Respiratory Disorders
        • Renal Diseases
        • Neurodegenerative Disorders
        • Genetic Disorders
        • Infectious Diseases
        • Other
      • Latin America Antisense & RNAi Therapeutics Market, by Route of Administration
        • Pulmonary Delivery
        • Intravenous Injections
        • Intradermal Injections
        • Intraperitoneal Injections
        • Topical Delivery
        • Other Delivery Methods
      • Brazil 
        • Brazil Antisense & RNAi Therapeutics Market, by Technology
          • RNA Interference
            • siRNA
            • miRNA
          • Antisense RNA
        • Brazil Antisense & RNAi Therapeutics Market, by Application
          • Oncology
          • Cardiovascular
          • Respiratory Disorders
          • Renal Diseases
          • Neurodegenerative Disorders
          • Genetic Disorders
          • Infectious Diseases
          • Other
        • Brazil Antisense & RNAi Therapeutics Market, by Route of Administration
          • Pulmonary Delivery
          • Intravenous Injections
          • Intradermal Injections
          • Intraperitoneal Injections
          • Topical Delivery
          • Other Delivery Methods
    • MEA 
      • MEA Antisense & RNAi Therapeutics Market, by Technology
        • RNA Interference
          • siRNA
          • miRNA
        • Antisense RNA
      • MEA Antisense & RNAi Therapeutics Market, by Application
        • Oncology
        • Cardiovascular
        • Respiratory Disorders
        • Renal Diseases
        • Neurodegenerative Disorders
        • Genetic Disorders
        • Infectious Diseases
        • Other
      • MEA Antisense & RNAi Therapeutics Market, by Route of Administration
        • Pulmonary Delivery
        • Intravenous Injections
        • Intradermal Injections
        • Intraperitoneal Injections
        • Topical Delivery
        • Other Delivery Methods
      • South Africa 
        • South Africa Antisense & RNAi Therapeutics Market, by Technology
          • RNA Interference
            • siRNA
            • miRNA
          • Antisense RNA
        • South Africa Antisense & RNAi Therapeutics Market, by Application
          • Oncology
          • Cardiovascular
          • Respiratory Disorders
          • Renal Diseases
          • Neurodegenerative Disorders
          • Genetic Disorders
          • Infectious Diseases
          • Other
        • South Africa Antisense & RNAi Therapeutics Market, by Route of Administration
          • Pulmonary Delivery
          • Intravenous Injections
          • Intradermal Injections
          • Intraperitoneal Injections
          • Topical Delivery
          • Other Delivery Methods

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.